Molecular Epidemiology of Neoplastic and Non-neoplastic disease
Sever infections represent the main cause of neonatal mortality accounting for more than one million neonatal death. Antibiotics are the common medication in neonatal intensive care unit. While there is a growing choice of agents against multi-resistant gram-positive bacteria, new options for multi-resistant gram-negative bacteria in the clinical practice have decreased significantly in the last 20 years making the treatment of infections caused by multidrug-resistant pathogens challenging mostly in neonates
- Biomarkers for detection of colonic neoplasms
- Disease nosology
- Molecular pathology of protest cancer
Related Conference of Molecular Epidemiology of Neoplastic and Non-neoplastic disease
September 14-15, 2026
6th World Congress on Tuberculosis, Lung Infections, and Respiratory Care
Paris, France
October 05-06, 2026
14th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs
Madrid, Spain
November 04-05, 2026
7th International Conference on Microbiology and Infectious Diseases
Barcelona, Spain
May 26-27, 2027
14th International Conference on Infectious Diseases, Bacteriology and Antibiotics
Paris, France
Molecular Epidemiology of Neoplastic and Non-neoplastic disease Conference Speakers
Recommended Sessions
- Antibiotic Resistance Leads to Increased Mortality
- Antibiotic Therapy and Antimicrobial Drugs
- Antimicrobial Agents and Chemotherapy
- Antimicrobial Agents and Novel Vaccines
- Antimicrobial Agents in Clinical Treatment
- Antimicrobial Pathogens : Alternative Approaches
- Antimicrobial Textiles Market
- Antimicrobial Therapy for Gum Disease
- Antimicrobiology in Epidemiology
- Community Acquired Antimicrobial Resistance: Is It Controllable?
- Global Antibacterial Drugs Market Key
- Infection Diseases and Agents
- Molecular Epidemiology of Neoplastic and Non-neoplastic disease
- Neuroinfectious Diseases
- Pediatric Infectious Disease
- Pharmalogical Consideration of Infectious Disease and Agents
- Plant Based Vaccines
- Veterinary Pathology and Infectious Diseases
Related Journals
Are you interested in
- Advances in Pulmonary Care and Rehabilitation - Tuberculosis 2026 (France)
- Advances in Tuberculosis Diagnosis - Tuberculosis 2026 (France)
- Alcohol and Drug Use - STD-HIV AIDS-2026 (Spain)
- Antimicrobial Resistance (AMR) - Infectious Meet 2027 (France)
- Antimicrobial Stewardship in Respiratory Care - Tuberculosis 2026 (France)
- Antimicrobial Stewardship/Antimicrobial Resistance - Infection Prevention 2026 (Spain)
- Bacterial & Fungal Infectious Diseases - Infectious Diseases_2026 (France)
- Bacterial and Parasitic Diseases - Infectious Meet 2027 (France)
- Bacterial Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Bacterial, Parasitic and Fungal Infections - Infection Prevention 2026 (Spain)
- Blood Borne Infections/Sepsis/Septicaemia - Infection Prevention 2026 (Spain)
- Causes and Symptoms of Infections - Infection Prevention 2026 (Spain)
- Causes and Symptoms of Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Clinical and Case Reports - INFECTIOUS DISEASES-2027 (France)
- Clinical Infectious Diseases and Case Management - Infectious Meet 2027 (France)
- Clinical Management of Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Clinical Research and Case Reports - STD-HIV AIDS-2026 (Spain)
- Clinical Research and Public Awareness - Infectious Diseases_2026 (France)
- Co-infections Associated with STD - STD-HIV AIDS-2026 (Spain)
- Coronavirus Disease (COVID-19) - INFECTIOUS DISEASES-2027 (France)
- Coronavirus(nCOV) - Infectious Diseases_2026 (France)
- Covid_19 Infections - Infection Prevention 2026 (Spain)
- Diagnosis and Treatment - STD-HIV AIDS-2026 (Spain)
- Diagnosis f infectious Diseases - Infection Prevention 2026 (Spain)
- Diagnostics and Laboratory Technologies - Infectious Meet 2027 (France)
- Digital Health and Disease Surveillance - Infectious Meet 2027 (France)
- Drug-Resistant Tuberculosis and Treatment Strategies - Tuberculosis 2026 (France)
- Ebola and Zika Viral Infections - Infectious Diseases_2026 (France)
- Emerging and Re-Emerging Infections - Infection Prevention 2026 (Spain)
- Emerging and Re-emerging Infectious Diseases - Infectious Meet 2027 (France)
- Emerging and Zoonotic Respiratory Infections - Tuberculosis 2026 (France)
- Environmental and Occupational Lung Diseases - Tuberculosis 2026 (France)
- Epidemiology - Infection Prevention 2026 (Spain)
- Epidemiology - INFECTIOUS DISEASES-2027 (France)
- Epidemiology and Public Health - Infectious Meet 2027 (France)
- Foodborne and Waterborne Diseases - Infectious Meet 2027 (France)
- Fungal Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Future Directions in Respiratory Medicine - Tuberculosis 2026 (France)
- Future Trends and Innovations in Infectious Diseases - Infectious Meet 2027 (France)
- Gastrointestinal and Urinary Tract Infections - Infection Prevention 2026 (Spain)
- Global Health and Policy - Infectious Meet 2027 (France)
- Global Health and Policy Approaches to TB and Respiratory Care - Tuberculosis 2026 (France)
- Global Trends in Emerging Infections - Infection Prevention 2026 (Spain)
- Global Trends in Emerging Infectious Diseases - Infectious Diseases_2026 (France)
- Hepatitis Prevention - Infection Prevention 2026 (Spain)
- HIV and Women's Health Issues - STD-HIV AIDS-2026 (Spain)
- HIV/AIDS - Infectious Diseases_2026 (France)
- HIV/AIDS and Sexually Transmitted Infections - Infectious Meet 2027 (France)
- Immunizations and Vaccination - Infection Prevention 2026 (Spain)
- Immunology and Host-Pathogen Interactions - Infectious Meet 2027 (France)
- Immunology of Infections - Infectious Diseases_2026 (France)
- Immunology of Tuberculosis and Respiratory Infections - Tuberculosis 2026 (France)
- Infection Control and Hospital-Acquired Respiratory Diseases - Tuberculosis 2026 (France)
- Infection Control in Critical Care - Infection Prevention 2026 (Spain)
- Infection Control Procedures - Infection Prevention 2026 (Spain)
- Infection Prevention and Control - Infection Prevention 2026 (Spain)
- Infection Prevention and Control (IPC) - Infectious Meet 2027 (France)
- Infection, Immunity and Inflammation - INFECTIOUS DISEASES-2027 (France)
- Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Infectious Diseases and Neuro Infectious Diseases - Infectious Diseases_2026 (France)
- Infectious Diseases Epidemiology - INFECTIOUS DISEASES-2027 (France)
- Infectious Diseases Prevention, Control and Cure - Infectious Diseases_2026 (France)
- Infectious Diseases Prevention, Control and Cure - INFECTIOUS DISEASES-2027 (France)
- Innovative Drug Delivery Systems for Respiratory Therapy - Tuberculosis 2026 (France)
- Internal Medicine for Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Malaria and Hepatitis - Infectious Diseases_2026 (France)
- Neuro Infections - Infection Prevention 2026 (Spain)
- Neuro Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- New Antiviral, Antibacterial and Antifungal Agents - Infectious Diseases_2026 (France)
- Nosocomial Infections - Infectious Diseases_2026 (France)
- Nosocomial Infections & Control - INFECTIOUS DISEASES-2027 (France)
- Nosocomial Infections and Control - Infection Prevention 2026 (Spain)
- Nutrition and Lifestyle Interventions in Respiratory Health - Tuberculosis 2026 (France)
- One Health Approach - Infectious Meet 2027 (France)
- Ophthalmological Infections - Infection Prevention 2026 (Spain)
- Pandemic Preparedness and Response - Infectious Meet 2027 (France)
- Parasitic Diseases - Infectious Diseases_2026 (France)
- Parasitology & Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Pediatric and Neonatal Respiratory Care - Tuberculosis 2026 (France)
- Pediatric HIV - STD-HIV AIDS-2026 (Spain)
- Pediatric Infectious Diseases - Infection Prevention 2026 (Spain)
- Pediatric Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Pediatric Infectious Diseases/ Childhood Infectious Diseases - Infectious Diseases_2026 (France)
- Pediatric Tuberculosis: Diagnosis and Management - Tuberculosis 2026 (France)
- Pharmacology of Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Plants Diseases and Infection Control - Infection Prevention 2026 (Spain)
- Public Health - STD-HIV AIDS-2026 (Spain)
- Pulmonary Critical Care and Intensive Management - Tuberculosis 2026 (France)
- Pulmonary Emergencies and Acute Care Management - Tuberculosis 2026 (France)
- Pulmonary Fibrosis and Chronic Lung Diseases - Tuberculosis 2026 (France)
- Pulmonary Hypertension and Vascular Lung Diseases - Tuberculosis 2026 (France)
- Pulmonary Imaging and Radiology - Tuberculosis 2026 (France)
- Pulmonary Oncology and Lung Cancer Management - Tuberculosis 2026 (France)
- Pulmonary Rehabilitation and Post-Infection Recovery - Tuberculosis 2026 (France)
- Rare Diseases in Cancer and Aging - Infectious Diseases_2026 (France)
- Rare Infectious Diseases - Infection Prevention 2026 (Spain)
- Rare Infectious Diseases and Immune Deficiencies - Infectious Diseases_2026 (France)
- Recent Advancements - STD-HIV AIDS-2026 (Spain)
- Research on Medicine and Vaccine for Covid-19 - INFECTIOUS DISEASES-2027 (France)
- Respiratory Diseases - Infectious Diseases_2026 (France)
- Respiratory Infections Beyond TB - Tuberculosis 2026 (France)
- Respiratory Infectious Diseases and Therapy - Infection Prevention 2026 (Spain)
- Respiratory Microbiome and Host Interactions - Tuberculosis 2026 (France)
- Sexual Health - STD-HIV AIDS-2026 (Spain)
- Sexually Transmitted Diseases - Infection Prevention 2026 (Spain)
- Sexually Transmitted Diseases - STD-HIV AIDS-2026 (Spain)
- Sexually Transmitted Diseases/ Sexually Transmitted Infections - Infectious Diseases_2026 (France)
- Surgical Site Infections - Infection Prevention 2026 (Spain)
- Surgical Site Infections - Infectious Diseases_2026 (France)
- Telemedicine and Digital Health in Respiratory Care - Tuberculosis 2026 (France)
- Testing and Health Monitoring - STD-HIV AIDS-2026 (Spain)
- Transmission and Prevention - STD-HIV AIDS-2026 (Spain)
- Tropical and Neglected Diseases - Infectious Meet 2027 (France)
- Tropical diseases - Infection Prevention 2026 (Spain)
- Tropical Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Tuberculosis - Infectious Diseases_2026 (France)
- Tuberculosis and Respiratory Infections - Infectious Meet 2027 (France)
- Vaccine Development and Immunization Strategies - Infectious Meet 2027 (France)
- Vaccine Development for Tuberculosis and Respiratory Infections - Tuberculosis 2026 (France)
- Vaccines and People with HIV - STD-HIV AIDS-2026 (Spain)
- Vaccines and Vaccination - Infectious Diseases_2026 (France)
- Vaccines and Vaccination - INFECTIOUS DISEASES-2027 (France)
- Veterinary Diseases - Infection Prevention 2026 (Spain)
- Veterinary Diseases - INFECTIOUS DISEASES-2027 (France)
- Viral Infections and Recent Advancements - Infection Prevention 2026 (Spain)
- Viral Infectious Diseases - Infectious Diseases_2026 (France)
- Viral Infectious Diseases - INFECTIOUS DISEASES-2027 (France)
- Virology and Viral Infections - Infectious Meet 2027 (France)
- Zoonotic and Vector-Borne Diseases - Infectious Meet 2027 (France)